From: Could KL-6 levels in COVID-19 help to predict lung disease?
Baseline characteristics | P values | |||||
---|---|---|---|---|---|---|
HSa (N = 70) | COVID19 (N = 83) | ILD (N = 31) | HS vs COVID19 | HS vs ILD | ILD vs COVID19 | |
Gender, M (%) | 35 (50%) | 52 (62.6%) | 23(72%) | > 0.05 | < 0.05 | > 0.05 |
Age | 58 (52–64) | 72 (58–82) | 69 (62–75) | < 0.001 | > 0.05 | < 0.01 |
Leukocytes (/ml) | 6.21 (5.13–7.43) | 6.3 (4.68–8.61) | 8.77 (6.1–11.53) | > 0.05 | < 0.01 | < 0.01 |
Neutrophils (/mm3) | 3.38 (2.81–4.22) | 4.65 (3.32–7.21) | 5.78 (4.31–8.19) | < 0.001 | < 0.001 | > 0.05 |
Lymphocytes (/mm3) | 2.2 (1.71–2.49) | 0.92 (0.65–1.23) | 1.97 (0.87–2.2) | < 0.001 | > 0.05 | < 0.001 |
CRP (mg/L) | 1.0 (0.5–2.4) | 60 (27–146) | 4.8 (2.1–9) | < 0.001 | > 0.05 | < 0.001 |
Fibrinogen (g/L) | 2.88 (2.56–3.43) | 5.24 (4.03–6.23) | 3.43 (3.18–4.15) | < 0.001 | > 0.05 | < 0.01 |
KL-6 (U/mL) | 254 (191–308) | 405 (277–592) | 897 (550–1885) | < 0.001 | < 0.001 | < 0.001 |